Covered recipient · General Payments record
GABRIEL MCCOY
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$3,043.02
- Reported across 143 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,121.47 | 54 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $179.08 | 8 |
| Ipsen Biopharmaceuticals, Inc | $92.25 | 4 |
| PFIZER INC. | $84.42 | 4 |
| GlaxoSmithKline, LLC. | $74.98 | 5 |
| Incyte Corporation | $66.31 | 3 |
| E.R. Squibb & Sons, L.L.C. | $64.08 | 4 |
| Genentech USA, Inc. | $60.77 | 2 |
| EMD Serono, Inc. | $48.14 | 2 |
| ARRAY BIOPHARMA INC | $38.58 | 2 |
| Merck Sharp & Dohme Corporation | $37.19 | 2 |
| Alnylam Pharmaceuticals Inc. | $36.31 | 1 |
| EISAI INC. | $35.48 | 2 |
| Acerta Pharma LLC | $34.84 | 1 |
| Apellis Pharmaceuticals, Inc. | $32.28 | 2 |
| Novocure Inc. | $25.36 | 1 |
| TerSera Therapeutics LLC | $24.53 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $22.92 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.14 | 1 |
| Celgene Corporation | $20.89 | 1 |
| SERVIER PHARMACEUTICALS LLC | $20.36 | 1 |
| TAIHO ONCOLOGY, INC. | $20.34 | 1 |
| Karyopharm Therapeutics Inc. | $20.25 | 1 |
| Acrotech Biopharma Inc. | $17.85 | 1 |
| Janssen Biotech, Inc. | $15.78 | 1 |
| Genmab U.S., Inc. | $13.80 | 1 |
| Janssen Pharmaceuticals, Inc | $13.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.